token,frequency
table,27
the fiscal year,110
the transition,1
period,20
name,5
registrant,1
chartercommissionfile,1
par,4
value,31
share,46
check,8
mark,8
the registrant,10
a wellknown seasoned issuer,1
oindicate,3
pursuant,17
section,10
such filing,1
no oindicate,2
corporate website,1
andposted pursuant,1
this chapter,2
post,1
disclosure,13
herein,4
definitive proxy,1
information,33
reference,64
any amendment,1
filer,6
a nonaccelerated filer,1
reporting,10
company,13
growthcompany,1
growth,28
Ã¾,1
o,1
odo,1
the extended transition,1
a shell,1
aggregate,1
market,42
stock,62
the closing,2
price,44
such stock,1
number,4
common stock,91
the following document,1
this report,9
annual meeting,2
refer,1
corporationamerisourcebergen,1
global pharmaceutical sourcing,3
distribution,39
patient access,3
patient care,2
the effectiveness,9
efficiency,11
the pharmaceutical supply,10
chain,15
animal health,10
acomprehensive offering,1
brandname,12
specialty,13
home,4
healthcare,36
suppliesand,1
equipment,19
a wide variety,4
acute care,5
health,22
order,10
care,21
site,4
dialysis,5
an assortment,1
research,9
pharmaceutical consulting,1
niche,1
premium,2
inventory,14
management,36
pharmacy,11
automation,2
solutionsindustry,1
an independent third party,1
provider,14
ofinformation,1
healthcare industry,1
a compound,1
annual growth,1
rate,47
the growth,6
part,27
pharmaceutical manufacturer,2
increasesin,1
addition,27
the pharmaceutical industry,1
the number,8
age,1
rapidlygrowing segment,1
the population,4
this age,1
group,4
the rest,1
asubstantial portion,1
total healthcare,1
development,7
the advent,1
new research,1
production,10
biotechnology,6
gene,1
therapy,2
delivery,8
industry,14
other specialty,5
the continued growth,3
emphasis,2
other third party,3
utilization,4
growthwe,1
the increase,26
generic usage,1
a favorable trend,1
gross profit,18
marginopportunity,1
revenue,67
approximately0,2
the prescription,1
volume,3
response,8
cost,22
containment,1
the use,6
efficient drug,1
national attention,1
the overall increase,1
drug,21
a beneficial impact,1
prolonged hospital,1
overall healthcare,1
anddevelopment,2
introduction,1
costeffective drug,1
regulation,5
the healthcare,9
an effort,3
andreduce,1
the federal government,1
major health,1
reform,4
legislation,7
access,8
insurance,12
thenumber,1
a portion,14
prescription,9
the health,2
law,9
reimbursement,19
enforcement authority,1
fraud,10
abuse,6
pharmaceutical andmedical device,1
the healthreform legislation,1
page,5
certain risk,2
business,90
diverse network,1
ofdistribution,2
service,18
pharmaceutical distribution,8
the primary supplier,1
a broad range,2
the efficiency,2
effectiveness,5
the delivery,4
channelstrategyour,1
strategy,9
the global pharmaceutical supply,1
channel,9
valueadded distribution,1
globalcommercialization,1
patient,3
further align,2
ourorganization,2
customer,34
unified way,4
corporate strategy,4
increaseoperating income,1
the execution,1
strategyoptimize,1
size,3
andmarket,1
breadth,1
operating,47
capital,20
position,9
competitiveness,1
a leader,1
community,3
plasma,4
other blood,4
support,11
the new biotechnology,1
the near futurewith,1
the genericmarketplace,1
generic product,2
private label,1
program,25
source,2
a valueadded genericformulary program,1
compliance,11
dataand,1
manufacturing,2
the expansion,2
international presence,1
global manufacturer,1
commercialization,4
strategywe,1
offer,1
theirpatient,1
assistance,2
rapid new product,1
marketing,4
product,10
logistical supportour,1
independent community,3
pharmaceutical benefit,1
merchandising,1
network,2
retail pharmacy,1
the country,1
andprivate label,1
hospital,1
packaging,5
institutional andretail,1
providers0,1
adistribution,1
facility,23
this network,1
a national distribution,1
center,5
incolumbus,1
a single shipping,1
destination,1
increasedproductivity,1
income,81
warehouse,2
technology,12
adopt,1
leverage,1
fullservice,2
businessesoptimize,1
the channel,1
ofreimbursement,1
contractfield,1
patient assistance,1
mitigation,1
other market,1
global specialty,4
transportation,4
the biopharmaceutical industryworld,1
platform,2
theintroduction,1
feed,4
the companion,1
animal,6
a variety,9
ecommerce,1
pharmacyfulfillment inventory,1
system,11
procurement,1
consultation,1
special order,1
fulfillment,1
core,3
strategic focus,1
certain noncore,1
time,44
additional divestituresoperationsoperating,1
structure,9
reportable segment,31
the purpose,7
presentation,5
the combination,4
the legacy,3
andamerisourcebergen,1
a single operating,3
segment,17
inconnection,4
the completion,3
this reorganization,3
nontitle third party,3
drugdistribution,1
strategic global sourcing,1
a comprehensive offering,3
acute,3
mail,6
a number,17
disease,3
reportablesegment,4
additional consulting,3
software,7
institutional healthcare,3
retail healthcare,4
providersotherother,2
global commercialization,3
a full suite,3
integrated manufacturer,3
clinical trial,3
toproduct,4
postapproval,3
transportationand,1
the biopharmaceutical industry,3
both thecompanion,1
force,4
the majority,4
geographic focus,1
type,1
national account,1
close coordination,1
local distribution,1
theirrespective product,1
an enterprisewide marketing,1
all other marketing,1
a diverse customer,1
base,3
pharmaceutical manufacturersinstitutional,1
other alternate,1
physician group,1
regional retaildrugstore,2
mass,2
typicallythe primary source,1
supply,5
overthecounter product,1
beauty,1
aid,1
the operating,2
ofhealthcare,1
the loss,13
any majorcustomer,1
relationship,7
future revenue,1
cash,85
none,2
the fiscalyear,5
a supplier,1
the primary source,1
a majority,1
fiscal year,13
purchasesinformation,1
primary enterprise,1
resource,2
planning,1
electronic order,1
entry,1
invoice preparation,1
purchasing,5
segmentsoperate,1
the ability,8
entitywide infrastructure,1
environment,2
speed,1
advanced information,1
example,3
other supply,1
custody,2
governmental0,1
pharmaceutical compounding,3
profitability,5
secure,1
the customer,6
aplatform,1
demand,4
replenishment,1
third party,9
realtime price,1
incentive,2
a substantial portion,1
purchase,17
electronic interface,1
transactional volume,1
the warehouse,1
productivity,3
leveragea,1
significant portion,1
providerscompetitionwe face,1
competitive global environment,1
the distribution,9
withinpharmaceutical distribution,1
ownwarehousing,1
credit,56
use,5
the principal,1
the course,1
the subject,3
registrationwe,1
other intellectual property,1
theconduct,1
such intellectual property,1
acombination,1
trade,23
secret patent,1
copyright,1
confidentiality,1
protectionswe,1
hold,1
relate,1
automated pharmacy,1
medication,1
certain warehousing,1
proprietary packaging,1
protection,4
proprietary intellectual property,1
the intellectual property,1
infringement,1
collective bargaining,2
other such bargaining,1
connection,27
the negotiation,1
the expiration,4
adequate contingency,1
place,4
the event,1
anysuch disruptions0,1
extensive oversight,1
state,41
federaland,1
storage,2
andor distribution,1
meetvarious security,1
comply,2
the sale,7
outsourcing,3
current good manufacturing,2
broad enforcement,2
all applicable pharmaceutical compounding,1
wholesale distribution,1
current operationswe,1
the federal antikickback,1
statute,3
the antikickback,1
receiving,2
any remuneration,2
the purchasing,1
leasing,1
a referral,1
lease ororder,1
arrange,1
any way,2
other federalhealthcare,1
the fraud,1
scope,1
the safety,2
the pharmaceutical supplychannel,1
the introduction,3
counterfeit,2
thedistribution,2
the federal level,2
the supply,7
security,15
federal traceability,2
the lot,2
level,2
pedigree,2
an electronic interoperable prescription,1
traceability,2
licensing,2
comparable state,1
wholesale distributor,1
additional change,1
the creation,2
a new category,2
compliancewith,1
no assurance,11
withadditional state,1
any failure,2
the cost,3
operationsfederal insurance,1
toexpand,2
coverage,9
a combination,5
an expansion,1
ofmedicaid,1
the formula,2
upper payment,1
multiple source,2
retail community,1
a nationwide basis,2
weighted average manufacturer,1
implementing,1
payment,12
brandedprescription,1
actual acquisition,1
prescription drug,2
programsas,1
a result,20
scrutiny,2
tocontinue,1
the state,3
this process,3
additional legislation,1
andor,15
the production,1
the structure,2
the present healthcare,1
the interpretationsof,1
significant additional compliance,1
the discontinuation,1
ability,18
a material adverse effect,10
financial condition,12
various federal state,2
respect,17
anddisposal,1
laboratory,1
practicesthe,1
the failure,3
a significant impact,3
financial conditionsee,1
risk,13
a discussion,1
other litigation,2
failure,9
financialconditionhealth,1
forth privacy,1
the privacy,1
the security,1
protected health,3
such term,2
regulationssome,1
maintain,2
andor access,1
ontheir location,1
the manner,1
productsare,1
violation,1
complianceprogram,1
andreinvestment,1
federal privacy,1
privacy,5
new notification,1
final rule,2
enforcement,3
act,1
the meaning,2
other personal information,1
sensitive personal information,1
such information,1
personallyidentifiable information,1
applicable privacy,1
website,4
the website,1
charge,12
discussion,3
these risk,1
tothose,1
forth,3
manufacturer,6
pricing,13
generic pharmaceutical launchesin,1
brand,8
generic pharmaceutical pricing,2
pharmaceuticaldistribution,1
profit,16
consolidated operating,1
a material,4
adverse effect,2
operationscertain distribution,1
compensation,19
component,1
subject tofluctuation,1
the timing,4
extent,2
the frequency,2
genericpharmaceutical price,1
pricedeflation,1
generic pharmaceutical price,1
deflation,5
the negative impact,1
the past,2
ofoperationscompetition,1
consolidation,5
profitas,1
detail,1
competitive inaddition,1
the impact,13
power,2
pressure,3
andstate,1
the pharmaceutical distribution,2
andpharmacy,1
diversion,6
counterfeitadulterated andor,1
the risk,4
various federal andstate,1
various state,3
recent yearssome,1
burden,2
pharmaceutical compoundingat,1
pedigree tracking,1
other chain,2
thepharmaceutical supply,1
trackandtrace andor authentication,1
datamatrix,1
the manufacturer,3
a standardized numerical identifiersni,1
guidance,4
the development,3
mandatedpackagelevel,1
an initial step,1
the drug,1
all supplychain,1
an electronic interoperable prescriptiondrug,1
such entitiesone additional change,1
thefda,2
compliancemoreover,1
draft,1
final guidance,1
the methodology,1
onoccasion price,1
pharmaceutical pricing,2
ouroperationsfederal insurance,1
an expansionof,1
the scope,1
the ongoing implementation,1
every aspect,1
the law,1
federal upper payment,1
retailcommunity,1
a limit,1
the weighted average manufacturer,1
outpatient drug,1
the weighted average,1
the rule,2
the actual acquisition,1
effective onapril,1
light,3
the actualacquisition,1
standard,2
the final rule,1
each state,1
reduction,2
multisource,1
profitabilitythe,1
rebate,5
minimum,2
the federalgovernment,2
the future,11
impact,1
drugsthere,1
an adverse impact,2
onour,1
the potential impact,1
inreimbursement,1
related reporting,1
outpatient,1
a positiveimpact,1
enactment,1
businessthe federal government,1
spending,2
instance,1
the sequestration,1
provision,8
cut,1
plan,31
this time,4
policy,7
an adverse effect,4
business0,1
other economic factorsour,1
oncology,6
anumber,1
a physicians office,1
private practice,1
hospitalprime,1
vendor,1
this trend,1
the past year,1
discount,3
the rate,2
physician servicesunder,1
a request,2
modelswhich,1
interest,51
rule,1
outpatient hospital,1
this rule,1
wouldnot,1
profitabilityour,1
financing,12
inthe,3
government,12
an increased reliance,1
funding,2
large sophisticated purchasing,1
tochange,1
a reduction,5
governmental funding,1
federal level,1
certainhealthcare,1
the amount,20
the price,4
willing topay,1
continued government,1
private payor,1
profitabilityif,1
other governmenthealthcare,1
andabuse,1
the referral,1
apatient,1
treatment,2
the ordering,1
other governmentsponsoredhealthcare,1
give federal enforcement,1
powersand,1
judicial authority,1
a manner,1
programs0,1
concern,1
the abuse,3
regulatory action,2
businesscertain,1
governmental,2
local governmental,1
multiple,1
the diversion,2
accordance,20
an intent,1
significant due diligence,1
control,8
harm,2
reputation,8
an early stage,1
the outcome,2
the adverse resolution,1
common stockour,1
qui tam litigation,2
other legal proceedingsour,1
the manufacture,1
dispensing,3
the defense,1
operationsand financial condition,1
the marketing,5
sale,8
canresult,1
administrative liability,1
possible exclusionfrom,1
participation,3
settlement,23
judgment,7
fine,1
excess,7
the basis,4
qui,2
tam,6
the qui,1
a private person,2
a relator,3
behalf,6
the federaland,1
the filing,3
a qui tam,1
complaint,3
the action,2
andordispensing,1
branded andor,1
wrongdoing,1
seal,4
the applicable court,1
federal district,2
organization,3
regard,4
any health,1
any portion,1
renewal,2
a significant customer,5
top ten,1
contractwith,1
such customer,2
tothe extent,1
such early termination,1
the contract,1
subject toexpiration,1
each year,2
renew renegotiate,1
any significant customer,1
expiration,4
date,14
flows0,1
realizedin,1
strategic arrangement,1
agreement,9
arrangement,12
avariety,1
acquisition,13
expectation,1
servicesarrangement,2
the potential,1
innovation,1
toachieve,1
the arrangement,1
an ongoing basis,1
issubject,1
the potential inability,1
potential benefitsresulting,1
improved generic drug,1
inability,2
generic manufacturersor,1
the potential disruption,1
the duration,1
any disruption,1
flow,13
stockholdersin,1
any reduction,1
financial flexibility,1
potential,1
supplier,4
the transaction,1
the overall strategic relationship,1
towork,1
an efficient,1
effective manner,1
furtherance,1
the relationshipin,1
the right,8
the obligation,3
the public market,1
commonstock,3
common stockwe,2
collaboration,1
andthe diversion,1
attention,1
the anticipated time,1
frame,1
a material adverse impact,1
financialcondition,1
common stocka disruption,1
generic purchasing,1
financial resultswe,1
the primary distributor,1
generic pharmaceutical program,1
the genericspurchasing,1
any reason,2
natural disaster,1
labor,1
disruptionregulatory,1
governmental action,1
an obligation,1
termination,1
allin addition,1
possible revocation,1
substance,1
pharmaciestax legislation,1
tax,103
financial conditionwe,1
a large corporation,1
theus federal state,1
the repeal,1
lastinfirstout,1
oureffective tax,1
historical tax,1
precedent,1
federal state,3
foreign tax,2
relevanttax,1
any such challengethe suspension,1
revocation,2
effect,6
compound,1
store,1
distribute,1
the refusal,1
any such facility,1
any enforcement action,1
governingdistribution,1
compounding,1
various securityand,1
compliancewith various security,1
the illegal diversion,2
a regulatory agency,1
tribunal,1
ithe ability,1
ii seize,1
recall,3
iii,1
operationswe,2
monitoring,1
other authority,1
agency,1
correspondence,1
timely manner,1
these responsesrequire,1
effort,2
the assertion,2
the commencement,2
civil criminal,1
regulatory legal proceedingsagainst,1
the suspension,1
each ofwhich,1
applicable current gmp,1
subsequent enforcement,1
the business,3
a warning,1
letter,2
the inspection,1
headquarters,1
the sufficiency,1
timing,2
meeting,1
a failure,4
regulatory authority,1
warning,1
an enforcementaction,1
license revocation,1
labelingor,1
death,3
reputational harmthe,1
labeling,2
hospitaloutpatient,1
ambulatory,1
surgery,1
the injury,1
a patient,1
quality,4
issuesmanufacturing,1
flaws improper packaging,1
human,1
other errorany,1
a recall,1
safety,2
the ordinary course,4
retrieval,1
negative publicity,1
publicity,1
a quality,1
issue,1
accurate orinaccurate,1
acceptance,1
decrease,7
result,2
liability,13
a class,1
multidistrict litigation,1
such action,1
litigation,39
reputational harm,1
patientharm,1
a competitor,1
a hospital pharmacy,1
operationsfinancial condition,1
liquidity,3
future insurance,1
insufficient,1
any liability,2
ofthe,2
a reasonable cost,1
reorganization,4
other business,2
process,6
initiativesin,1
a new organizational structure,1
below,1
the organization,2
a level,1
improvement,1
optimization,1
manage,2
success,1
the reorganization,1
andother,2
distraction,1
disruption,3
attrition,1
toattract,1
reduced employee,1
restructuring,1
any restructuring,1
initiative,2
the desired benefitsour,1
any particular time,2
assessmentdiscussion,1
negotiation,1
public disclosure,1
pendingand,1
operational experience,1
ormore,2
the near orlong term,1
the assumption,1
the fair value,34
the imposition,3
adequate,1
the integration,2
antibribery anticorruption,1
international trade,1
businessfinancial position,2
weare,1
subject,19
export,2
sanction,1
similar anticorruption,1
any violation,1
substantial liability,1
a loss,9
ofreputation,1
the market,6
favorable treatment,1
an adequate system,1
disgorgement,1
suspension,1
ordebarment,1
contract,17
foreign government,2
international business,1
timeconsumingand,1
an adverse outcome,2
any such investigation,2
audit,6
financial position,1
global operationsour,1
inflation,5
recession,1
currency,4
volatility,11
competition,2
financial conditionour,1
performance,11
depend,1
a decrease,9
ourprofitability,1
the general economy,1
financial market,3
discretionary spending,1
bad debt,3
expense,70
affectedour stock,1
the capital,3
significant disruption,1
movement,1
material,2
ourability,1
businessour,1
the bankruptcy,4
insolvency,6
other credit,4
a significant customermost,1
ourassessment,1
analysis,5
creditworthiness,1
a security,1
creditexposure,1
the position,1
andcredit,1
the solvency,2
orcreditworthiness,2
any customer,1
a substantial amount,1
amaterial adverse effect,1
receivable,2
rise,1
any supplier,1
a time,1
the supplier,3
a substantial accountpayable balance,1
sophisticated information,3
process analyze,1
the purchase,8
anddistribution,1
numerous distribution,1
ship,1
a timely basis,1
otherproduct,1
the accurate billing,1
the new patient,1
supporttechnology,1
ecosystem,1
the implementation,2
providersare,1
a significant portion,3
the extent,5
a third partyservice,1
the information,4
the actionsof third partiesinformation,1
the proliferation,1
sophisticationand,1
cyber,3
breach,2
the disclosure,3
misuse,1
confidential orproprietary information,1
the continueddevelopment,1
enhancement,1
attack,1
damage,1
a priority,1
robust information,1
any information,1
the international transfer,2
that regulate,1
thecollection,1
transfer,3
the transfer,5
these foreign dataprivacy,1
collection,1
businessand,1
financial positionour,1
goodwill,11
a significant charge,2
generallyaccepted accounting,1
principlesus,1
accounting,16
impairment,4
anannual basis,1
potential impairment exist,1
relativeto,1
significant negative industry,1
a significant decline,1
capitalization,2
asustained period,1
a change,1
intangible assetsmay,1
divestiture,2
a business,1
asset,5
a rise,1
ininterest,1
the accuracy,2
validity,2
the period,15
any impairment,1
such charge,1
a materialadverse impact,1
insurancethe occurrence,1
financial performance,1
physical damage,1
partial closure,1
longterm disruption,2
climate,1
change,3
thepharmaceutical distribution,1
energy,2
the availability,5
nature,1
occur,1
combination,1
operationsitem,1
office,4
warehousespace,1
lease,2
wholesale pharmaceutical distribution,1
comprise,1
squarefeet,1
the world,1
an aggregate,4
satisfactory conditionitem,1
following,5
a list,2
executive,4
experience,1
yearsmr,3
the company,72
yearsms,2
executive leadership,1
for0,1
andpresident,1
various leadership,1
the trading,1
symbol,1
were0 record,1
low closing,1
lowfiscal year,1
quarter,6
0fiscal year,1
board,22
the quarterly dividend,3
ourboard,1
dividend,4
quarterly cash,2
thefuture,1
the payment,5
amount,10
the discretion,3
other factorscomputershare,1
agent,2
co,1
telephone,1
internet wwwcomputersharecom0,1
the total number,2
the average price,1
ofpublicly,1
the approximate dollar,1
each month,2
the fiscal,1
ain,1
a share,5
repurchase program,14
the existingaugust,1
subject tomarket,2
transaction,14
a financial institution,7
the financial institution,2
a total,17
authorization,5
a new share,5
this program,12
ofavailability,2
repurchase,1
graph,1
year,7
cumulative total,1
stockholder,1
the performance,2
an index,1
peer,1
the graph,2
the common stock,3
thenew,1
represent fiscal yearend,1
index,3
the last trading,1
day,2
eachfiscal quarter,1
inwholesale pharmaceutical distribution,1
reinvestment,1
dividends0,1
conjunction,4
thereto,14
loss,30
common share,1
net,34
debt,18
current portion,3
equity,24
gain,16
antitrust litigation,18
net ofincome tax,1
employee,21
severance,26
benefit,26
expense net,9
of0,8
employeeseverance,2
pension,8
benefitof,1
chargeon,1
an equity,1
investment,10
no income,1
early retirement,1
fromantitrust litigation,1
hereinwe,1
pharmaceuticaland,1
biotech,1
serviceswe provide,1
separate reportable segment,1
previouslyreported segment,1
a material impact,9
historical reportable segment,2
staffing,2
softwareto,2
the companionanimal,2
summary,5
the prior fiscal year,47
the revenue,1
segmenttotal gross profit,1
the reduction,1
lastin,1
firstout,4
acredit,1
the current fiscal year,9
comparison,9
an expense,1
an increase,23
grossprofit,1
other offset,2
greatergeneric deflation,1
the prior fiscal yeardistribution,1
selling,8
a percentage,16
thecurrent,1
basis,41
point,3
decline,3
the decrease,7
tothe,3
second half,1
certain administrative functionstotal,1
andour effective tax,1
effective tax,10
thefiscal year,7
offset,5
the benefit,2
option,10
exercisesand,1
the receipt,2
private letter,3
ruling,3
an income,3
deduction,4
exercise0,1
future,1
industrygrowth,1
new innovative brand,1
the likely increase,1
certain drug,1
conversion,1
the industry,1
downward pressure,1
federal government,1
rulesand,1
legacy,11
the presentation,3
respectivelylegacy,2
overall market,2
the retail customer,1
a decline,1
strong overall performance,1
businessa number,1
flowsotherrevenue,1
strong growth,1
companionanimal,1
launches0,1
lowerbrand,1
generic deflation,1
the prior fiscal yearour,2
mix,2
manufacturerpricing,1
the above,2
factorsmay,1
the current fiscal yearwas,1
the prior year,2
a prior year,1
contractrenewal,1
appreciation,5
contribution,6
assurance,1
patient safety,1
inpart,1
margin,9
lowerprice appreciation,1
margingross,2
andmwi,1
the prior fiscal yearwe,1
changedistribution,2
amortization,12
total,3
was0,1
the second half,1
administrative functionsdepreciation,1
property,5
infrastructure,1
various technology,1
the amortization,2
warrantsexpense,1
millionemployee severance,1
dealrelated transaction,7
ofemployee severance,1
contribution0k,1
the settlement,8
total segment,3
intangiblesamortization,1
ingross,1
the priorfiscal year,1
the gross profit,2
expenses0,1
the respective weighted average interest,2
construction,2
inaverage,1
invested cashour,1
exercisenet income,1
legacyabdcs revenue,1
legacyabsgs revenue,1
ourthird party,1
blood,1
vaccine,1
physician office,1
a significant contract,1
a fiveyear term,1
the previouscontractsotherrevenue,1
incremental revenue,1
fromthe,1
millionincrease,1
generic drug,1
thecontribution,1
the incremental income,1
generic,2
lowergeneric price,1
generic price,4
andkaiser,1
ingeneric price,1
the contribution,1
other of0,1
the addition,3
ofmwi,1
respectivelyoperating,1
0acquisition,1
higheroperating,1
an initiative,1
certain administrative functionsdepreciation,1
serviceamortization,1
prior fiscal year,1
andpharmedium,1
the decline,4
strategic relationship,1
millioncharge,1
acquisitionwe,1
a pension,3
the final settlement,1
salarieddefined benefit,1
gross profitoffset,1
theprior fiscal year,1
issuance,15
variablerateterm,1
loan,7
average borrowing,1
the currentfiscal year,1
the recent variablerate,1
ratesour,1
exercise,7
ratesnet income,1
net loss,1
financialposition,2
past experience,1
the application,2
a complete list,1
significant accounting,1
net ofan,1
allowance,12
a reserve,2
return,6
full value,2
full credit,3
the time,4
ofsale,1
historical customer,1
trendsin,1
the appropriate allowance,1
the aging,2
receivablesindustry,1
financial strength,1
standing,2
default,2
history,2
othersmay lead,1
the calculation,2
the required allowance,2
the ultimate realization,2
probable bad debt,2
historical experience,6
specific credit,2
collectability,2
each business,1
unit,6
theallowance,1
a consistent manner,1
the bad debt,1
forany period,1
end,3
other adjustmentsschedule,1
a rollforward,1
the allowance,2
reserve,4
the provision,2
accountsreceivable,1
fair value,16
the residual,2
appraisal,1
the management,1
estimatesequity,1
the equity,2
method,19
significant influence,2
anownership interest,2
otherthantemporary impairment,1
acomponent,1
that determination,2
an impairment charge,4
minority,4
ownership,8
a pharmaceutical wholesaler,1
the impairment charge,3
ourdetermination,1
the date,17
the investment,6
no impairment,2
forimpairment,2
a qualitative assessment,3
likely thannot,1
the qualitative assessment,2
the fourth quarter,8
the goodwill,3
the current year,3
aqualitative assessment,1
the qualitative annual assessment,1
infuture,2
periodsthe,1
impairment test,3
the reporting,4
thefair value,1
no further evaluation,2
no impairment loss,2
the fair valuethe,1
difference,1
an impairment loss,2
the total amount,2
a particular operating,1
companyresideswe,1
an incomebased approach,2
the incomebased approach,2
a discounted cash,4
an appropriate discount,2
a sale,2
the annual goodwillimpairment,2
test,6
depreciationamortization capital,1
longrange,2
the discount,2
an estimate,3
theoverall aftertax rate,1
a market,2
participant,3
weighted average cost,2
both debt,2
a riskpremium,1
available information,2
actual future,2
future impairment,2
overall methodology,2
a comparison,2
the fairvalue,4
the indefinitelived intangible asset,2
the asset,3
the relief,6
royalty,6
valuation,6
technique,1
the discounted cash,2
namesand,1
a royalty,2
use0 table,1
required annual impairment,2
uncertain tax,4
assessment,2
tobe,1
financial reporting,34
net operating,3
purposeswe,1
a valuation,2
certain deferred tax,1
the required valuation,1
application,1
the valuation,4
weanticipate,1
the other deferred income,1
abovewe prepare,1
file,1
interpretation,1
record,2
the normal course,2
examination,3
lawresulting,1
court,1
applyingcomplex tax,1
the tax,7
an uncertain taxposition,1
the taxing,2
the positionwe,1
deferred tax,10
reasonable judgment,1
a different estimate,1
resolution,3
the amountsaccruedthe,1
the preceding,1
paragraphs,1
the ultimate effective tax,1
subpoenas government,1
investigationsand,1
antitrust commercial environmental product,3
intellectual property,3
regulatory employment,1
discrimination,2
a liability,4
an assessment,2
the materiality,2
aloss,1
an additional loss,2
areasonable possibility,1
contingency,2
the likelihood,2
a reasonable estimate,2
the range,2
the firstin,2
current replacement,2
toany,1
provision0,1
account,1
the compensation,2
a binomial option,3
model,4
sharebased compensation,9
expected term,1
the option,2
riskfree interest,1
yield,1
forfeiture,2
the expected term,1
historical volatility,1
the grant,4
the compensationexpense,1
the nonvested performance,1
periodic assessment,3
the probability,3
estimate,2
various price,2
the judgment,2
thestatus,1
the specific incentive,2
any other pertinent information,1
a continual basis,2
the reserve,2
appropriate,2
decreasein cost,1
the ultimate outcome,2
any outstanding claim,2
estimateliquidity,1
availability,5
the multicurrency,1
securitization,9
note,6
the overdraft,1
facilityin,1
total fixedrate debt,1
variablerate debt,5
0total debt,2
sufficient capital,1
outstanding debt,1
primary ongoing cash,1
fund,5
the repayment,1
routine growth,1
expansionthrough new business,1
requirementsas,1
dollar,1
nonus,1
subjectto shortterm intercompany,1
taxation,1
repatriation,1
thiscash,1
build,1
balance,3
shortterm capital,1
intraperiod,2
shortterm working capital,1
advance,1
revolving,1
cumulative intraperiod,1
term,2
loanswe,1
multicurrency,2
senior unsecured revolving,1
a syndicate,2
uponour debt,1
rating,4
thealternate base,1
canadian prime rate,2
the total commitment,1
any time,4
a financial leverage,3
ratio,3
impose limitationson,1
indebtedness,2
a commercial paper,2
an aggregate amount,2
the program,2
bearing,2
a discount,2
the commercial paper,3
capacity,4
commercial paper,4
the capacity,1
tomake,1
anaccordion feature,1
the commitment,2
approval,5
shortterm commercial paper,1
fee,2
a customary unused fee,2
a revolving basis,2
a whollyowned special purpose,2
entity,3
turn,2
receivables,2
theservicer,1
additional receivables,2
tothe maximum,1
the facility,4
a financing,2
vehicle,1
an attractive interest,2
relative toother,1
sourceswe,1
an uncommitted unsecured line,2
a principal amount,1
the bank0,1
prior notice,2
overdraft,2
normal trading,1
cycle,1
businessin,1
variablerate term,4
the scheduled repayment,4
principal payment,4
maturity,6
a rate,4
a base,8
a margin,8
orlibor,1
the margin,4
public debt,2
thecash consideration,1
the acquisition,7
a scheduled principal payment,2
0million,3
bearsinterest,1
the cash,2
consideration,2
arrearsin,1
a program,2
thisshare repurchase program,1
sharerepurchase,1
the initialpayment,1
funded stock,1
holdback,2
the volumeweighted average price,2
the term,4
inaddition,1
ourcommon stock,4
thisprogram,1
this programin,2
the right topurchase,1
a minority,4
assumingtheir exercise,1
an exercise,6
a sixmonth period,3
b,4
a sixmonthperiod beginning,1
a contract,5
a series,2
ofissuer,1
this hedge,2
a total premium,4
a premium,2
the cap price,2
strike,2
net share,2
special share,2
dilutive effect,7
warrant,1
series,2
issuer,3
call,4
the above premium,3
a special share,3
underall,1
this special share,2
this availability,2
theybecame,1
the sixmonth period,1
obligation,6
afinancial institution,2
the special share,2
ownaccount,1
timethe,1
a summary,3
ournoncancelable operating,1
the portion,2
future minimum lease,2
the accounting,2
owner,2
the financing,3
noncash termination,2
the financingobligationwe,1
outsource,1
commitment,3
the above tableour,1
this liability,1
anestimate,1
theamount,2
any future cash,1
reasonable certainty,1
the result,4
net income,3
merchandise,6
primarily0,1
depreciation,5
deferred incometax,1
a current year,1
see,4
a gradual change,2
amendment,2
the customerdeterioration,1
operationswe use,1
hand,2
an annual average,1
the day,1
the week,1
the month,1
increase,1
ofincome tax,1
millionand,3
inmerchandise,1
ouroverall,1
significant capital,1
initiativesincluding,1
enterprise,1
trackandtracetechnology,1
national distribution,1
expansion,1
trackandtrace,1
unitscost,1
ourpharmedium acquisition,1
acquisition0,1
repayment,1
common stocknet,1
theexercise,1
the exercise,4
repurchaseprogramwe,1
millionin,2
the potential dilution,1
these financing,1
quarterly dividend,1
increasesdividend,1
anticipate,2
other factorsmarket,1
exposure,6
fixedrate andvariablerate debt,1
the year,4
variable interest,1
rateshowever,1
the unfavorable impact,1
a hypothetical decrease,1
the favorable impact,1
annual net interest,1
minimal exposure,1
foreign currency,8
exchange,6
foreign exchange,2
approximatelyone percent,1
consolidated revenue,1
rateswe,1
trading,1
the foreign currency,2
outstanding note0 table,1
thisreport,1
likely outlook,1
forecast,1
intend plan,1
sustainsynergy,1
track,1
seek estimate,1
uncertainty,2
future performance,1
incorrect,1
frequency,1
deflationcompetition,1
pharmaceutical market,1
regulatory environment,1
public concern,1
opioid medicationsprosecution,1
suit,1
shareholder,1
federal scrutiny,1
materialadverse resolution,1
the retention,1
key customer,1
the adverseresolution,1
any contract,1
other dispute,1
supplier payment,1
the strategiclongterm,1
the pharmaceutical distributionagreement,1
the global generic,1
adverse resolution,1
withthe,1
difficult tointegrate,1
the inability,1
foreign expansion,1
noncompliance,1
antibribery,1
inpayment material,1
bankruptcy,2
a major customer,1
a majorsupplier,1
mix malfunction,1
the impairment,1
a charge,2
the disruption,1
other economicbusiness competitive legal tax,1
ii,1
iv,2
v,2
significant market,1
thecompanys common stock,1
herein0,1
consolidated balance,1
and0,5
comprehensive income,5
the financial statement,1
schedule,5
the index,1
the responsibility,1
responsibility,2
an opinion,2
andschedule,1
auditswe,1
the audit,4
reasonable assurance,9
misstatement,1
an audit,2
a test,1
evidence,1
the overall financial statement,1
a reasonable basis,2
opinion,3
all material,4
the consolidated financial position,1
conformity,2
the related financialstatement,1
relation,1
setforth,1
thereinwe,1
internal control,23
report,3
anunqualified opinion,1
thereon,2
s,5
doubtful accounts0,1
0total property,1
accumulated depreciation,1
paidin capital,1
other comprehensive loss,2
consolidated financial statements0,5
translation,5
status,1
adjustment net,1
other comprehensive income,1
comprehensive loss,1
repurchase transaction,1
accelerated share,1
repurchasetransaction,1
net cash,1
0provision,1
deferred income,2
excess tax,1
beginning,1
animal healthbasis,1
all intercompany,1
consolidationthe preparation,1
the preparation,4
continued reasonableness,1
imputation,2
a debt,1
the balance,5
sheet,6
a direct reduction,1
the face,1
the debt,1
an asset,1
the lineofcredit,2
regardless,2
a retrospective basis,1
thereclassification,1
the adoption,4
no impact,3
all income,1
the income,1
statement,2
an employer,1
withholding,1
a policy,1
election,1
annual reporting,4
periodsbeginning,1
the quarter,3
a cumulative adjustment,1
the establishment,1
a deferred tax,4
the excess tax,1
future periodsin,1
the test,1
a hypothetical purchase,1
allocation,1
a goodwillimpairment,1
any interimgoodwill impairment,1
annual goodwillimpairment,2
financialposition0 table,1
supersedesthe,1
recognition,2
industryspecific guidance,1
throughoutthe,1
a single comprehensive model,1
principle,10
a company,1
anamount,1
the consideration,1
the entity,1
the effective date,1
yearin,1
versus,1
principal versus,1
no 0 revenue,1
the guidance,2
the original public entity,1
effective date,1
retrospective application,1
a preliminaryassessment,1
adoption,2
the newstandard,1
this preliminary assessment,1
this standard,2
the method,1
transparency,1
andcomparability,1
key information,1
a modified retrospective application,1
theadoption,1
this new accounting,2
diversity,1
practice,1
the statement,2
annual period,1
a retrospective application,1
financialstatementsas,1
adoptionbusiness,1
acquisitioncash,1
ofcash,1
a large number,1
other alternatecare,1
independent community0,1
the financial condition,3
industrythe,1
receivable net,1
second largestcustomer,1
collateral,1
theultimate realization,1
financial conditionand,1
a consistentmanner,1
reputable credit,1
thereforebear minimal credit,1
tomitigate,1
money,2
equivalentscontingenciesloss,1
governmentsubpoenas government,1
intellectual propertyregulatory employment,1
a reasonable possibility,1
ofthe loss,1
uponthe receipt,1
a recovery,1
the antitrust litigation,1
designationand,1
tradingpurposesthe company,1
an impairmentcharge,1
a component,3
apharmaceutical wholesaler,2
the determination,2
the0,1
the functional currency,1
the applicable local currency,1
the current exchange,1
the weighted average exchange,1
future yearsthe,1
the reportingunit,1
the difference,1
a particular operatingcompany,1
residesthe,1
each reporting,1
marginsdepreciation,1
the overall aftertax rate,1
a risk,1
unchangedthe impairment test,1
the impairment testing,1
techniquefor,1
the straightline,2
the assetsincome,1
a method,1
the need,1
some portion,1
the deferred tax,1
an uncertain tax,1
uponexamination,1
the positiontax,1
the recognition,2
probableoutcome,1
full disclosure,1
a tax,2
examinationinvestment,1
marketable debt,4
the appropriateclassification,1
each balance,1
marketabledebt,1
either shortterm,1
longterm,1
contractual maturity,1
shortterm,1
the exception,1
inthe current period,1
the specific identification,1
availableforsale,1
all ofwhich,1
the construction,1
the owner,1
the significance,1
project,2
a corresponding financingobligation,1
completion,1
a saleleaseback,1
therelated financing,1
continuinginvolvement,1
the related financing,1
the life,1
the lease term,1
an operating,2
leaseand,1
the related lease,1
a straightline basis,3
theexpected lease term,1
the related inventorymerchandise,1
the lastin,1
reportedas,1
andlifo expense,1
provisionproperty,1
machinery,1
maintenance,2
computer,1
internal use,1
the projectreach,1
stage,2
preliminary stage,1
all other postimplementation,1
usingthe straightline,1
yearsrevenue,1
persuasive evidence,1
an arrangement,1
renderedthe price,1
the accompanying,1
other customer,1
incentivesthe,1
returnedto,1
the gross dollar,1
bulk,2
the express direction,1
drop,1
crossdock,2
immediate shipment,1
a principal,1
the primary obligor,1
contractual responsibility,1
fulfillment andacceptability,1
full risk,1
the creditworthiness,1
any bulk,1
any year,1
restricted stock,11
datemarket,1
the requisite service,4
the same line,1
item,1
associatedwith,1
nonvested performance,3
estimateof,1
issuedthe income,1
no tax,1
pick pack,1
andadministrative,1
these reserve,1
the status,4
other pertinent information,1
thecompanys estimate0 table,1
a binomial lattice,1
andthe,1
the vesting period,1
the end,5
an adjustment,1
hadbeen,1
the remeasurement,1
full see,1
a purchase,1
billionmwi,1
the acquisitionthe purchase,2
the net tangible,2
the fair valueof,2
receivable inventory,2
the trade,1
an indefinite life,1
incometax purposeson,1
a leading national provider,1
the acquired softwaretechnology,1
useful life,1
deductible forincome tax,1
purposesnote,1
a leading pharmaceutical wholesaler,1
a joint venture,1
enhanced specialtydistribution,1
the brazilian marketplace,1
inprofarma,1
the specialty,4
joint,2
venturethe,1
joint venture,2
relating,4
ownershipinterest,1
a minorityinterest,1
venture0,1
foreign income,2
reconciliation,2
federal income,2
the effective income,1
rate0,3
local income,1
federal tax,1
benefit0,1
allowance0,1
compensation0,1
nondeductible litigation,1
assuccessor,1
that time,1
a fair value,1
the approximate tax,1
deductible amount,1
the 0year term,1
any value,1
the initial fair value,1
onthe date,1
a private letter,1
aresult,1
adjustment,1
the estimatedbenefit,1
the issuance,4
this tax,1
benefitadjustment,1
the aggregate,1
the total fair value,1
respective exercise,2
an additional tax,1
the change,1
the future tax,1
0capital loss,1
carryforward,1
potential tax,4
fromfederal net operating,1
foreign net operating,3
federal alternative minimum taxcredit,1
foreign alternative minimum tax,1
federal research,1
theaddition,1
certain state,2
valuationallowance,1
this amount,1
wereno tax,1
respectivelythe,1
federal jurisdiction,1
the aggregate tax,1
taxreturn,1
federal benefit,1
income0 table,1
the effective tax,1
the unrecognized tax,1
ofinterest,1
the beginning,1
unrecognized tax,4
anuncertain,1
civil litigation,1
deferred federal income,1
the eventual repatriation,1
thereafternote,1
0total net,1
senior unsecured credit,1
the alternate base,1
the totalcommitment,1
aswell,1
borrowing,1
an accordion,1
feature,1
lender,1
theavailability,1
the servicer,1
the maximum amount,1
other financing,1
accountswhich,1
noninterest bearing,1
a principal amountnot,1
the bank,1
shortterm normaltrading cycle,1
businessterm,1
equal eitherto,1
the public debt,2
to0 basis,1
containssimilar,1
thecompany,6
pointsover,1
wascompliant,1
the stated interest,1
the table,1
additional indebtedness,1
the repurchase,1
preferred stock,2
creation,1
certain corporate actssuch,1
an additional covenant,1
informationscheduled future,1
thereafterinterest,1
the above indebtedness,1
respectivelytotal amortization,1
the accretion,1
original issue,1
authorized capital,1
asotherwise,1
the board,7
no voting,1
the respective series,1
the same dividend,1
vote,1
the exclusive right,1
a per,1
directorsfrom,1
the initial payment,1
the financialinstitution,1
theright,1
thecompanys,3
open market,2
full inconnection,1
subject tothe,1
areduction,2
capitalin,1
a special program,1
an opportunity,1
hedging,1
common stockfor,1
sharesof,1
sharedilution,1
concurrent,1
thecompanys treasury,1
a firstin,2
firstout basis,2
a reissuance,2
the sixmonthperiod,1
treasury,1
forthe,1
own account,1
the weighted average number,2
the dilutive effect,1
outstanding fiscal year,1
respectivelynote,3
outstanding common stock,1
a related party,1
a pharmaceutical distribution,1
an agreement,4
favorable economic pricing,1
a generic purchasing,1
ofseptember,1
various retirement,1
a deferred compensation,1
eligible employeesthe compensation,1
theadministration,1
retirement,1
other benefit,1
an internal committee,1
senior finance,1
performanceof,1
the termination,2
a salaried defined benefit,1
regulatory approval,1
theplan,1
andthe purchase,1
a nonparticipating annuity,1
the plan,3
the relateddeferred tax,1
assets0,1
the surplus,1
a defined contribution,1
salaried andcertain,1
regular compensation,1
the participant,2
each additional0,1
bythe,2
an additional discretionary contribution,1
an amount,2
the salaried definedbenefit,1
eligible calendar,1
the direction,1
the employee,2
creditedservicethe,1
this unfunded plan,2
keymanagement,1
total cash,1
the annual compensation,2
limit,2
this plan,2
an annual amount,1
total cashcompensation,1
key management,1
annualcompensation,1
equivalentsare,1
fractional number,1
the average,1
ofcommon stock,1
each full share,1
underthe deferred compensation,1
deferred compensation,1
the granting,2
nonqualified stock,2
a price,2
the fair market,3
grant,5
afouryear service,1
expire,2
director,3
thecommon stock,1
a threeyear service,1
nonemployee director,1
theamerisourcebergen,1
thehistorical volatility,1
implied market,1
historical exercise,1
takinginto,1
options0,1
yieldcurve,1
grantthe,1
yield0,1
common stock0,2
life,1
the above valuation,1
respectivelya,4
activity,1
related information,1
ispresented belowin,1
contractual term,1
intrinsic value,1
belowin,1
expected future compensation,2
is0,2
a weighted average period,2
the product,1
restricted sharesis,1
yearsperformance,1
certain executive,1
represent common stock,1
the futureperformance,1
a threeyear performance,1
achievement,1
specific performance,1
the target,1
award,2
the grant date,1
performancestock,1
target,1
amountsin,1
the threeyear performance,1
salary,1
the last business,1
each sixmonth purchase,1
each participant,1
each calendar,1
theopen market,1
thepurchase,1
rental expense,1
noncancelable operating,1
minimum lease,1
thecompanys commitment,1
other fiscal year,1
surplus,1
dispute,1
total employee,1
other costs0,1
salaried definedbenefit,1
thesettlement,1
a period,2
the form,1
a lumpsum payment0,1
regulatory employmentdiscrimination,1
theloss,1
rangeof,1
other outcome,1
any subsequent reporting,1
that period,1
promotion,1
the qui tam,1
the federal state,1
the relator,1
a confidential basis,1
the complaint,3
the court,1
the casewas,1
the government,4
the participation,2
the case,3
mayseek,1
a civil penalty,1
false claim,1
forpayment,1
the investigation,1
orsettlement,1
consumer,1
lawseither,1
a government,1
investigation,1
collateral litigation,1
class,3
action,3
strictliability,2
thefdca,1
a qui,1
grouppurchasing,1
various government,1
a customer,1
other industry,1
acooperative manner,1
these mattersare,1
subsidiary,5
the prefilled syringeprogram,1
certain oncology,1
dialogue,2
a plea,1
a guilty plea,1
a onecount,1
misdemeanor,1
the agreement,7
a total criminal fine,1
the guilty plea,1
the federal criminal investigation,1
thefailure,1
register,1
a complianceagreement,1
inprinciple,1
entirety,1
subjectto negotiation,1
execution,2
the satisfactory resolution,1
certainother,1
the resolution,1
any potential administrative action,1
a subpoena,2
a grand jury,1
the matter,2
subpoenas,1
grand jury,2
testimony,1
additional information,1
audits,1
anadministrative subpoena,1
subpoena,1
a negotiated settlement,1
conclusion,1
canbe,1
drawn,1
any likely outcome,1
this matter,2
all federal law,1
matter,1
the dispensing,1
that product,1
the same matter,1
stipulation,1
withprejudice,1
portion,2
the previouslydisclosed0,1
all eligible statesparticipate,1
theparticipating,1
prejudice,2
any state,1
the authority,1
billing,1
the subpoenafor,1
theirimpact,1
trial,2
the amountand,1
conduct,1
corporate integrity,1
criminal penaltiesopioid,1
alleging,1
illegitimate,1
toreport,1
other equitable relief,1
a settlement,1
thepayment,1
express denial,1
any wrongdoing,1
significant number,1
opioidpain,1
opioid,2
pain,2
onbehalf,1
a county,1
controlledsubstance,1
common law,1
negligence public nuisance,1
unjust enrichment,1
seek equitablerelief,1
monetary damageson,1
a motion,1
a single federal court,1
this motion,1
intent,1
a position,1
the likely outcome,1
a coalitionof,1
ofprescription,1
this request,1
andwill,1
a complaint,1
the original complaint,1
a prime vendor,1
current complaint,1
inexcess,1
partial summary judgment,1
counterclaim,1
the litigation,2
a onetime,1
paymentfrom,1
this agreement,1
a stay,1
a minorityinvestor,1
certain brand,1
plaintiff,1
any ofthese class,1
a member,1
the class,1
the abovementioned class,1
attorney,1
separate reportable segmentdisclosure,1
onglobal commercialization,1
additionin connection,1
distributionbusiness,1
itspreviouslyreported segment,1
a materialimpact,1
resultsthe,1
chief,1
decision,1
maker,1
whosefunction,1
providersother,1
the elimination,1
other income,1
lossimpairment charge,1
corporate office,1
segmentthe,1
expensethe,1
0total capital,1
shortterm nature,1
the money,1
inputsthe,2
no investment,1
securitiesavailableforsale,1
the amortized cost,1
longterm debt,3
the corresponding fair value,2
the recorded amount,1
administrative expensesdepreciation,2
other b,1
0operating income,1
first quarter,1
the first quarter,1
respectivelybthe third quarter,1
accrual fiscal year,1
expense income,1
other andpension,1
include,2
a definitive agreement,1
independentwholesaler,1
new longterm debt,1
thetransaction,1
regulatory review,1
other closing,1
early calendar,1
national wholesaler,1
fullline distribution,1
clinicsthe acquisition,1
strategic scale,1
thecompanys support,1
a regular quarterlycash dividend,1
that information,2
thetime,1
disclosuresthe,1
theexchange,1
theperiod,1
the fiscal quarter,6
maintainingadequate internal control,1
the reliability,4
andthe preparation,1
internal controlover,1
pertain,2
the maintenance,2
reasonable detail,1
preparation,2
withus,1
prevention,2
timely detection,2
unauthorized acquisition,2
disposition,2
a material effect,2
the financial statementsbecause,1
anyevaluation,1
the degree ofcompliance,2
this assessment management,1
public accounting,1
firm,3
an attestation,1
effective internal control,3
overfinancial reporting,1
the companys internal control,1
auditwe,1
an understanding,1
the design,3
performing,1
opiniona companys internal control,1
a process,1
financialreporting,1
companysinternal control,1
provide,2
the companys,1
thefinancial statementsbecause,1
any evaluationof effectiveness,1
asof,1
criteriawe,1
operationscomprehensive income,1
ofamerisourcebergen,1
an unqualified opinion,1
the close,1
the fiscal yearinformation,1
this reportwe,1
copy,1
anyprovision,1
websiteitem,1
herein byreferenceitem,1
referenceitem,2
reference0,1
list,1
the following,1
the following financial statement,1
toitem,1
the applicable accounting,1
toexhibit,7
trustee,9
exhibit,9
onmarch,4
corporation,3
form,2
thefiscal quarter,2
byreference,10
theregistrant,3
originator,3
buyer,5
party,14
seller,11
servicer,5
the variouspurchaser,1
administrator,5
amongamerisource,4
thepurchaser,4
purchaser,1
the purchaser,4
asadministrator,2
assignee,2
byand,1
asperformance,1
guarantor,2
favor,1
recipient,1
theborrowing,1
administrative agent,1
partythereto,1
any security,1
holder,1
the reasonable cost,1
reproductioneach,1
a management,1
a compensatory,1
a director,1
executive officer,1
the undersigned thereunto,1
duly,1
atbeginningof,1
atend,1
an allowance,1
respectively0,1
rent,1
a noncash expense,1
respectivelyloss,1
no such impairment charge,1
or0,1
the incorporation,1
certification,4
knowledge,5
any untrue statement,2
a material fact,2
omit,2
fact,2
other financial information,2
thefinancial condition,2
officer,4
defined inexchange,2
such disclosure,4
supervision,2
toensure,2
material information,2
prepared b,2
such internal control,4
oursupervision,2
theeffectiveness,2
such evaluation,2
d,2
any change,2
mostrecent fiscal quarter,2
fourth fiscal quarter,2
an annual report,2
recent evaluation,2
committee,2
operation,2
summarize,2
financial information,2
a significant role,2
internalcontrol,2
myknowledge,1
ofmy,1
staff,1
request,1
this certification,1
is a wellknown seasoned issuer,1
Ã¾ no oindicate,2
submitted andposted pursuant,1
submitand post,1
contained herein,1
accelerated filer,4
emerging growthcompany,1
emerging growth,2
use the extended transition,1
is a shell,1
Ã¾the aggregate,1
voting stock,1
improve patient access,3
enhance patient care,2
increase the effectiveness,2
distribute acomprehensive offering,1
including acute care,1
mail order,1
alternate site,4
reimbursementand pharmaceutical consulting,1
andpackaging solutionsindustry,1
impact the growth,1
ongoing research,2
continued growth,1
used brandname,1
increased emphasis,1
managed care,3
consider the increase,1
reduce revenue,1
rising healthcare,1
adopted cost,1
encourage the use,1
believe drug,1
had a beneficial impact,1
continued emphasis,1
continuing introduction,1
existing drug,1
increase drug,1
enacted major health,1
expand access,1
increased thenumber,1
costs the health,1
including drug,2
expanded disclosure,1
enhanced enforcement authority,1
prevent fraud,1
offer a broad range,2
enhance the efficiency,1
improve the delivery,2
provide valueadded distribution,1
pharmacies health,1
increase channel,1
improve patient,1
supporting corporate strategy,2
accelerating growth,4
focused strategy,1
grow revenue,1
improve the efficiency,1
allowing the pharmaceutical supply,1
deliver healthcare,1
are a leader,1
serviceand support,1
offer a valueadded genericformulary program,1
provide dataand,1
includes the expansion,1
include assistance,1
enables independent community,1
connectsour retail pharmacy,1
purchasing andprivate label,1
has adistribution,1
includes a national distribution,1
achieve increasedproductivity,1
operating income,14
implement warehouse,1
increase operating,1
increasing volume,1
consulting service,1
supporting access,1
staffing patient assistance,1
copay assistance,1
risk mitigation,1
leading global specialty,4
established platform,1
micro feed,4
divested certain noncore,1
consider additional divestituresoperationsoperating,1
requireseparate reportable segment,1
operating segment,3
provide drugdistribution,1
reduce healthcare,1
improve patient outcomesthe,1
distributes a comprehensive offering,3
overthecounter healthcare,3
including acute,3
provides pharmaceutical distribution,3
including plasma,3
provides pharmacy,3
supply management,3
provides a full suite,3
leading animal health,4
marketing the majority,1
has support,1
serve national account,1
receiving service,1
have an enterprisewide marketing,1
have a diverse customer,1
include acute care,2
longterm care,3
are typicallythe primary source,1
enhance the operating,1
affect future revenue,1
be the primary source,1
operating segmentsoperate,1
drive efficiency,1
automated warehouse,1
regulate the pharmaceutical supply,2
strengthen customer,1
allowing the customer,1
lower operating,1
providing aplatform,1
including product,1
singlesourcebilling third party,1
processing realtime price,1
processes a substantial portion,1
manage the majority,1
related healthcare,1
include price,1
valueadded service,1
are the subject,1
processes software,1
facilitate theconduct,1
protect such intellectual property,1
imposed protectionswe,1
dispensing equipment,1
seekpatent protection,1
assert infringement,1
existing collective bargaining,1
have adequate contingency,1
assure delivery,1
compounding purchase,1
licenses meetvarious security,1
governing the sale,2
have broad enforcement,2
powersincluding the ability,1
including the federal antikickback,1
offering receiving,2
paying any remuneration,2
induce the purchasing,1
induce a referral,1
purchase lease ororder,1
protect the safety,2
prevent the introduction,1
became law,3
establishes federal traceability,2
including licensing,1
regulationsgoverning wholesale distributor,1
is the creation,2
achieve compliancewith,1
be no assurance,11
increase the cost,1
intended toexpand,2
including coverage,2
reforms an expansion,1
fundthe coverage,1
changed the formula,2
require state,1
apply payment,1
reduce prescription drug,1
expected tocontinue,1
governing the production,1
have a material adverse effect,9
continueto purchase,1
handling anddisposal,1
have a significant impact,2
set forth privacy,1
protect the privacy,1
collect maintain,2
depending ontheir location,1
strengthened federal privacy,1
governing protected health,1
imposed new notification,1
including sensitive personal information,1
protecting such information,1
complywith applicable privacy,1
following discussion,2
describes certain risk,1
set forth elsewhere,1
couldhave a material,1
aninflationbased compensation,1
be subject tofluctuation,1
accelerates the negative impact,1
increasing consolidation,1
have a material,1
bargaining power,1
including state,1
regulate the pharmaceutical distribution,1
prevent diversion,1
include operating,1
impose pedigree tracking,1
andor burden,1
handling product,1
securing thepharmaceutical supply,1
include trackandtrace andor authentication,1
develop a standardized numerical identifiersni,1
issued guidance,1
regarding the development,1
secure the drug,1
require all supplychain,1
licensed such entitiesone additional change,1
achieve compliance,1
issue draft,1
reducing reimbursement,1
changing the methodology,1
been the subject,1
regulationimpacting pharmaceutical pricing,1
affect ouroperationsfederal insurance,1
reforms an expansionof,1
predict the impact,2
covered outpatient drug,1
requires state,1
increase minimum,1
have an adverse impact,2
mitigate the potential impact,1
increased the use,1
had a positiveimpact,1
have an adverse effect,3
declining reimbursement,2
sells specialty,1
provides anumber,1
caused a number,1
reduce the rate,1
issued a request,1
include prescription drug,1
valuebased purchasing,1
proposed rule,1
adopted wouldnot,1
existing inthe,1
include an increased reliance,1
expect the healthcare,1
continue tochange significantly,1
governing prescription,1
cause healthcare,1
reduce the amount,1
are willing topay,1
expect continued government,1
reduce pharmaceutical pricing,1
healthcare fraud,2
involving healthcare,1
induce the referral,1
impose a number,1
designated health,1
increased funding,1
suspected fraud,1
offered inconnection,1
including the loss,1
indicated an intent,1
diversion control,1
involves the manufacture,1
governing the marketing,2
any settlement,1
form the basis,1
filed the qui,1
authorize a private person,1
acts the filing,1
purchasing organization,2
lose a significant customer,2
existing contractwith,1
expiration tothe extent,1
extend renew renegotiate,1
be realizedin,1
provides avariety,1
negotiating acquisition,1
continued cost,1
purchasing servicesarrangement,2
exploring innovation together,1
needed toachieve,1
including the potential inability,1
realize andor,1
realizing potential benefitsresulting,1
including improved generic drug,1
expected the potential disruption,1
extended the duration,1
including any disruption,1
return value,1
continue towork collaboratively,1
has the right,2
prevailing market,5
decreased revenue,1
have a material adverse impact,1
are the primary distributor,1
have an obligation,1
existing distribution,1
controlled substance,1
are a large corporation,1
existing precedent,1
purchase compound,1
regulate the distribution,1
meet various securityand,1
andpreventing the illegal diversion,1
ensure compliance,1
including ithe ability,1
detect the illegal diversion,1
enforce compliance,1
received a warning,1
0following the inspection,1
resolved a failure,1
including a failure,2
andor license revocation,1
patient harm,1
freestanding hospitaloutpatient,1
are a number,1
including quality,1
labeling flaws improper packaging,1
regarding a quality,1
reduce market,1
lead toproduct,1
represent a class,1
establish multidistrict litigation,1
any such action,1
prove insufficient,1
cover any liability,1
increasing cost,1
maintain insurance,1
obtain insurance,1
satisfy any liability,1
announced a new organizational structure,1
align the organization,2
whilesupporting corporate strategy,2
improving efficiency,1
assume a level,1
integrateas part,1
make public disclosure,1
lack operational experience,1
including litigation,1
risks the fair value,1
pending the imposition,1
conduct business,2
create substantial liability,1
cause a loss,2
retaining business abroad,1
obtaining favorable treatment,1
maintain an adequate system,1
receive export,1
including inflation,1
do business,2
affect the amount,2
cause a decrease,2
including interest,2
obtain credit,2
reduce discretionary spending,1
incur bad debt,1
disruptionif the capital,1
experience significant disruption,1
experiencedownward movement,1
be material,1
existing credit,1
obtain a security,1
affect the solvency,2
has a substantial amount,1
have amaterial adverse effect,1
give rise,1
has a substantial accountpayable balance,1
facilitate the purchase,1
receive process,1
manage the accurate billing,1
managing a significant portion,1
increased sophisticationand,1
orunauthorized access,1
remain a priority,1
have robust information,1
remediate any information,1
record a significant charge,2
accepted accounting,9
thecarrying value,1
considered a change,1
carrying value,15
meet business,1
affect the accuracy,2
have a materialadverse impact,1
affect the availability,1
existing insurance,1
provide protection,1
is a list,2
joining the company,1
held management,1
increased the quarterly dividend,3
pay quarterly cash,2
forth the total number,1
purchased the average price,1
authorized a share,2
permitted the company,2
authorized a new share,5
allowing the company,4
including reinvestment,1
including current portion,1
contained hereinwe,1
increasethe effectiveness,1
require separate reportable segment,1
nothave a material impact,1
was acredit,1
improve operating,5
announced plan,1
expectour revenue,1
biosimilars the likely increase,1
increased downward pressure,1
expiration each year,1
anyexisting contract,1
increased revenue,1
have a material impact,8
enhance product,1
offset inpart,1
abovementioned contract,1
andcertain administrative functionsdepreciation,1
benefit pension,2
defined contribution0k,1
acquisitionrelated intangiblesamortization,1
expense employee,3
efficiencyoperating income,2
operating expenses0,1
leased construction,1
toan income,1
including an increase,1
contentsduring the fiscal year,1
lower brand,1
lower generic price,2
has higheroperating,1
improveoperating efficiency,1
defined contribution,4
recorded a pension,2
finance a portion,3
bear interest,3
involve accounting,1
require the use,1
presented net ofan,1
estimated customer,3
determining the appropriate allowance,1
consider a combination,1
requires judgment,2
ongoing credit,2
forth a rollforward,1
returnsbad debt,1
acquired business,2
engage third party,1
assist management,1
require management,1
expected cash,1
existing technology,1
have significant influence generally,1
represents anownership interest,2
be otherthantemporary impairment,1
recorded an impairment charge,3
were no impairment,2
tested forimpairment,2
perform a qualitative assessment,2
performing the qualitative assessment,2
completed aqualitative assessment immediately,1
perform the qualitative annual assessment,1
carrying amount,1
exceeds the fair valuethe,1
exceed the total amount ofgoodwill,2
utilize an incomebased approach,1
forecasted cash,2
determine the fair value,4
reporting unit,1
use a discounted cash,2
make a number,2
working capital,6
is an estimate,1
includes both debt,2
including a riskpremium,1
recorded goodwill,2
changing business,2
remainedunchangedthe impairment test,1
testing date,1
estimate the fair value,1
using the relief,2
believe the relief,1
used valuation,2
pay a royalty,2
established a valuation,1
described abovewe prepare,1
result infuture,1
recognize the tax,1
applying reasonable judgment,1
develop a different estimate,1
change an increase,1
havecaused income,1
including antitrust commercial environmental product,3
record a liability,1
perform an assessment,1
provide disclosure,1
assesswhether a reasonable estimate,1
used the firstin,2
approximates current replacement,1
utilize a binomial option,1
determine the fairvalue,1
involves the use,1
including expected term,1
expected volatility,1
represents the period,1
implied volatility,1
considering thestatus,1
adjust the reserve,1
including availability,1
revolving credit,8
thereceivables securitization,1
generated cash,1
haveprovided sufficient capital,1
fund capital,1
ongoing cash,1
be subjectto shortterm intercompany,1
reinvest thiscash,1
canrequire the use,1
fund shortterm capital,1
cover shortterm working capital,1
cover a portion,1
securitization facility,1
based uponour debt,1
pay facility,1
maintain the availability,3
including compliance,2
have a commercial paper,1
borrowing capacity,1
utilized the capacity,1
elected tomake,1
bears interest,3
whereby the commitment,2
lender approval,1
plusa program,1
pay a customary unused fee,1
sells a percentage,2
is theservicer,1
collected additional receivables,2
use the facility,1
offers an attractive interest,2
have an uncommitted unsecured line,1
shortterm normal trading,1
required principal payment,4
made a scheduled principal payment as,2
totaling 0million,1
authorized a program,1
programduring the fiscal year,1
granted the right topurchase,1
diluted basis,2
hedging strategy,4
executed a series,1
included the purchase,2
paid a premium,2
increase the cap price,2
have expiration,1
permitted net share,2
therefore the above,1
executed warrant,1
executeda series,1
therefore the above premium,3
authorized a special share,3
hedging a portion,2
deliver common stock,1
is a summary,3
be the accounting,2
exclude the future,2
services a significant portion,2
remaining commitment,2
represents anestimate,1
estimated liability,1
tableduring the fiscal year,1
comprised primarily0,1
support the increase,1
statements the increase,1
was the result,2
extended the term,1
changesin the ability,1
operating cash,2
refundsduring the fiscal year,1
expanding distribution,2
included technology,1
support customer,1
ordering trackandtrace,1
used a portion,1
fund a portion,2
hedge the potential dilution,1
following quarterly dividend,1
remainwithin the discretion,1
have market,2
manage interest,1
using a combination,1
have minimal exposure,1
is approximatelyone percent,1
utilize foreign currency,1
hadone foreign currency,1
denominated contract,2
hedges the foreign currency,2
expect likely outlook,1
project intend plan,1
continue sustainsynergy,1
believe seek estimate,1
prove incorrect,1
increasing pressure,1
impactprescription drug,1
regarding the pharmaceutical supply,1
increased public concern,1
including shareholder,1
increased federal scrutiny,1
including qui tam litigation,1
costsincluding the reserve,1
initiatives the acquisition,1
are difficult tointegrate,1
including the integration,1
theretomanaging foreign expansion,1
including noncompliance,1
toreturn value,1
set forth ielsewhere,1
changing interest,1
accompanying consolidated balance,1
included the financial statement,1
are the responsibility,1
express an opinion,2
perform the audit,2
obtain reasonable assurance,2
evaluating the overall financial statement,1
respects the consolidated financial position,1
yearsin the period,1
respects the information,1
expressed anunqualified opinion,1
funded status,1
restricted share,4
reconcile net income,1
including excess tax,1
enhance patient,1
indicated all intercompany,1
requires management,1
0simplifying the presentation,1
had no impact,2
requires all income,1
allows an employer,1
withouttriggering liability,1
make a policy,1
simplifying the test,1
requires a hypothetical purchase,1
be the amount,1
outlines a single comprehensive model,1
recognize revenue,1
depict the transfer,1
reflects the consideration,1
deferred the effective date,1
clarifies the implementation,1
issuedasu no 0 revenue,1
whichamends the guidance,1
identifying performance,1
modified retrospective application,1
evaluate the impact,2
conducted a preliminaryassessment,1
expect adoption,1
thecustomer this preliminary assessment,1
adopt this standard,1
evaluating the method,1
increase transparency,1
regarding lease,1
accounting standard,1
adopting this new accounting,1
estimate the impact,2
reduce diversity,1
evaluating the impact,1
ofadopting this new accounting,1
issued accounting,1
be cash,1
veterinarians the financial condition,1
require collateral,1
considers a combination,1
financialstrength credit,1
accounts the calculation,1
maintains cash,1
exceed the amount,1
monitoring the risk,1
seeks tomitigate,1
monitoring the investment,1
resolve the company,2
records a liability,1
performs an assessment,1
provides disclosure,1
realized uponthe receipt,1
represent a recovery,1
were the subject,1
uses the equity,1
has significant influence generally,1
is the applicable local currency,1
using the current exchange,1
ratesfor the period,1
resulting translation,1
alsocompleted a qualitative assessment immediately,1
requires the company,3
exceeds the fairvalue,1
uses an incomebased approach,1
operating marginsdepreciation,1
rateis an estimate,1
equityincluding a risk,1
andor market,1
remained unchangedthe impairment test,1
estimates the fair value,2
believes the relief,1
using the straightline,2
using a method,1
requires recognition,1
assessing the need,1
establish a valuation,1
recognizes the tax,1
sustained uponexamination,1
met the recognition,1
determines the appropriateclassification,1
underlying contractual maturity,1
deemed the owner,1
total project,1
project the company,1
performs a saleleaseback,1
have continuinginvolvement,1
using the lastin,1
whichapproximates current replacement,1
capitalizes project,1
depreciated usingthe straightline,1
recognizes revenue,1
been renderedthe price,1
reports the gross dollar,1
is a principal,1
is the primary obligor,1
bears full risk,1
bears full credit,1
grantsusing a binomial option,1
be issuedthe income,1
were no tax,1
warehouse pick pack,1
deliver inventory,1
considering the status,1
andany other pertinent information,1
using a binomial lattice,1
approach the fair value,1
eachreporting period,1
record the impact,1
measured fair value,1
recognizing expense,1
exceeded the fair value,2
goodwill the fair valueof,2
established a deferred tax,2
acquired customer,2
have an indefinite life,1
includedcertain purchase,1
is a leading national provider,1
estimated useful life,1
completed the acquisition,1
launched a joint venture,1
provide enhanced specialtydistribution,1
invested a total,1
otherthantemporaryin the fiscal year,1
held a minorityinterest,1
sharebased compensation0,1
was an estimate,1
be tax,1
received a private letter,1
recorded a deferred tax,1
recognized a tax,1
represented the estimatedbenefit,1
had a significant impact,1
reflect the future tax,1
following tax,1
operating loss,1
varying expiration,1
increased the valuation,2
ondeferred tax,1
carryforwardsin the fiscal year,1
file income,1
reduced income0 table,1
ending amount,1
excluding interest,1
ofunrecognized tax,1
estimate theamount,1
0revolving credit,1
pays facility,1
has a commercial paper,1
forshortterm commercial paper,1
pays a customary unused fee,1
maintain theavailability,1
is the servicer,1
is a financing,1
has an uncommitted unsecured line,1
provides the company,1
fund shortterm normaltrading cycle,1
incurred inconnection,1
stockholders the repurchase,1
requires compliance,1
have no voting,1
have the exclusive right,1
accumulated other comprehensive loss,1
granted theright,1
purchase a minority,1
exercisableduring a sixmonth period,1
allowed the company,2
paidin capitalin,1
authorized a special program,1
itexecuted a series,1
strategyduring the fiscal year,1
recognized a reissuance,2
deliver commonstock,1
considered a related party,1
including a pharmaceutical distribution,1
sponsors various retirement,1
covering eligible employeesthe compensation,1
delegated theadministration,1
approved the termination,1
obtained regulatory approval,1
settle theplan,1
completed the settlement,1
remaining obligation,1
transferred the surplus,1
recorded a charge,1
is a defined contribution,1
covering salaried andcertain hourly,1
invested bythe,1
salary an additional discretionary contribution,1
selected keymanagement,1
contributed an amount,1
exceeded the annual compensation,1
exceeds the annual compensation,1
defer a portion,1
including dividend,1
issued underthe deferred compensation,1
granted option,1
estimated fair value,3
forfeitures the company,1
using a binomial option,1
uses historical exercise,1
granted fiscal year,1
recognized stock,1
presented belowin,1
recognized restricted stock,1
recognized performancestock,1
have thecompany,1
recorded rental expense,1
represents thecompanys commitment,1
0during the fiscal year,1
settled salaried definedbenefit,1
records a reserve,1
noted the amount,1
related litigation,1
permit a private person,1
knownas a relator,1
including the filing,1
includes strictliability,1
including a qui,1
require time,1
requesting production,1
ongoing dialogue,1
entered a guilty plea,1
paid a total criminal fine,1
resolves the federal criminal investigation,1
duly register,1
reached an agreement,2
is subjectto negotiation,1
obtaining the satisfactory resolution,1
including the resolution,1
received a subpoena,2
andmonitoring diversion,2
requesting grand jury,1
served anadministrative subpoena,1
the0 subpoena,1
reach a negotiated settlement,1
requesting information,1
disclosed matter,1
involving the dispensing,1
executed settlement,1
dismissed the matter,1
include payment,1
provided all eligible statesparticipate,1
have the authority,1
recognized a liability,1
predict the outcome,1
failed toreport,1
including the company,2
regarding the distribution,3
childrens service,1
including negligence public nuisance,1
filed a motion,1
assess the likely outcome,1
received a request,1
investigating a number,1
regarding this request,1
filed a complaint,1
entered judgment,1
pending judgment,1
expects no impact,1
obtained a stay,1
formed entity,1
entering the market,1
named plaintiff,1
been a member,1
are net,1
require separate reportable segmentdisclosure,1
focus onglobal commercialization,1
revised itspreviouslyreported segment,1
have a materialimpact,1
operating resultsthe,1
operating decision,1
assess the performance,1
indicated fiscal year,2
represent the elimination,1
operating segmentthe,1
assessing performance,1
includes depreciation,1
deferred financing,1
had no investment,1
recorded amount,1
signed a definitive agreement,1
fund the acquisition,1
held national wholesaler,1
provides fullline distribution,1
expands thecompanys support,1
declared a regular quarterlycash dividend,1
maintains disclosure,1
ensure that information,2
required disclosuresthe,1
haveevaluated the effectiveness,1
provide reasonable assurance,5
regarding the reliability,4
reporting andthe preparation,1
thati pertain,1
permit preparation,2
regarding prevention,1
have a material effect,2
deteriorateamerisourcebergens management,1
assessed the effectiveness,1
making this assessment management,1
set forth,1
registered public accounting,1
issued an attestation,1
ofamerisourcebergens internal control,1
maintaining effective internal control,1
obtaining an understanding,1
assessing the risk,1
evaluating the design,1
operating effectiveness,1
assessed risk,1
provides a reasonable basis,1
is a process,1
assuranceregarding prevention,1
reporting asof,1
expressed an unqualified opinion,1
including information,5
incorporated herein,2
incorporated herein byreferenceitem,1
isincorporated herein,1
amended bythe,1
filed onmarch,4
incorporated byreference,10
servicerthe purchaser,1
marked exhibit,1
is a management,1
caused this report,1
capitalized interest,2
estimated interest,1
expense a noncash expense,1
includes an impairment charge,1
was no such impairment charge,1
contain any untrue statement,2
certifying officer,4
maintaining disclosure,2
designed such disclosure,2
caused such disclosure,2
being prepared b,2
designed such internal control,2
caused such internal control,2
evaluated the effectiveness,2
record process,2
report financial information,2
involves management,2
have a significant role,2
reporting s,2
certify pursuant,2
adopted pursuant,2
respects the financial condition,2
written statement,1
the fiscal year ended,103
share registered,1
the registrant is,3
the registrant is not,1
the registrant was,2
the registrant has,2
this chapter is not,1
growthcompany see,1
filer accelerated filer,1
company o,1
company oif,1
company indicate,1
stock held,1
the following document are,1
this report indicated,1
corporationamerisourcebergen is,1
equipment outsourced,4
research reimbursementand,1
management andpackaging,1
healthcare industry are,1
rate is,3
total healthcare expenditures,1
therapy continue,1
addition increased,1
growthwe consider,1
national attention has,1
therapy has,1
anddevelopment is,1
industry has,3
the federal government enacted,1
legislation designed,1
drug costs,1
law provides,1
industry enhanced,1
strategy is,1
strategy has,1
the genericmarketplace including,1
program based,1
offer valueadded,1
rapid new product launches,1
generic product purchasing,1
pharmacy consulting,1
network totaling,1
this network includes,1
contractfield staffing,1
structure resulting,3
reportable segment was,3
the pharmaceutical supply channel,1
reportable segment distributes,3
reportable segment provides,3
pharmaceutical distribution including,3
reportablesegment provides,3
pharmacy managementstaffing,1
providersotherother consists,2
force is,1
care pharmacies,1
the fiscalyear ended,5
supply are,1
fiscal year ended,7
segment operates,1
inventory tracking,1
information systemsin,1
replenishment singlesourcebilling,1
the warehouse operating,1
business have,1
registrationwe have,1
supply dispensing,1
marketing compounding,1
distribution ofcontrolled,1
broad enforcement powersincluding,1
any way paid,2
counterfeit diverted,1
legislation known,3
additional change resulting,1
insurance including,1
market reforms,2
insurance mandates,2
regulation governing,1
the interpretationsof existing,1
storage handling,1
such term is,2
andor access protected,1
productsare provided,1
security breachesbroadened,1
other personal information including,1
personallyidentifiable information is also,1
the website are not,1
discussion describes,1
tothose set,1
subject tofluctuation based,1
deflation accelerates,1
profitas described,1
section beginning,1
consolidation including,1
andpharmacy compounding,1
pharmaceutical distribution is,1
counterfeitadulterated andor mislabeled,1
guidance regarding,1
such entitiesone additional change resulting,1
no assurance that0,1
pharmaceutical pricing including,1
coverage including,1
the rule requires,1
the rule was generally,1
program has,1
cut is,1
segment sells,1
this trend has,1
information seeking,1
wouldnot have,1
funding affecting,1
the federalgovernment continues,1
fraud affecting,1
chain regarding,1
business involves,1
a private person known,1
a relator imposes,1
andor dispensing,1
group purchasing,2
business relating,2
such early termination is,1
agreement including,1
revenue decreased,1
financial resultswe are,1
generic pharmaceutical program has also,1
servicesarrangement does not,1
financial conditionwe are,1
legislation resulting,1
marketing packagingcompounding,1
time investigate,1
iii impose,1
operationswe have,1
the future receive,1
regulatory authority including,1
business are,3
business sells,1
safety alert,1
publicity including,1
reputational harm resulting,1
death caused,1
ofthe increasing,1
a new organizational structure described,1
below designed,1
unified way whilesupporting,2
corporate strategy accelerating,1
optimization initiatives,1
pendingand completed,1
litigation risks,1
operationswe are,1
acquisition described,1
the general economy including,1
business do not,1
a substantial amount owed,1
the supplier has,1
provider does not,1
reputation increase,1
damage orunauthorized,1
access remain,1
security measures,1
relativeto expected,1
following is,5
common stock is,1
lowfiscal year ended,1
0fiscal year ended,1
other factorscomputershare is,1
the average price paid,1
ofpublicly announced,1
the fiscal yearended,1
the availability remaining,1
repurchase program permitted,2
the company entered,4
transaction was,5
the financial institution delivered,2
repurchase program allowing,7
the company purchased,10
ofavailability remaining,2
graph depicts,1
the graph assumes,1
capitalization consists,1
index including,1
share amounts,1
share diluted,1
debt including,1
of0 milliondincludes,1
of0 millioneincludes,1
hereinwe are,1
historical reportable segment operating,2
summary provides,1
segmenttotal gross profit increased,1
the current fiscal year was primarily,2
revenue was,1
decline compared,2
fiscal year was primarily,2
the fiscal year endedseptember,7
thefiscal year ended,7
exercisesand restricted,1
stock vesting,2
compensation wererecorded,1
revenue growthbased,1
segment grew,2
segment offset,2
such customer expires,1
profit increased,2
the prior fiscal year was primarily,4
factorsmay have,1
gross profit decreased,1
the increase was primarily,2
the current fiscal year decreased,2
the prior fiscal yearwe recognized,1
expense increased,4
equipment placed,2
charge related,2
total segment operating,3
segment operating,4
income is,3
expense acquisitionrelated,2
income decreased,1
margin offset,2
operating efficiencyoperating,1
expense net increased,2
compensation were,3
exercisenet income was,1
legacyabdcs revenue was primarily,1
growth including,1
legacyabsgs revenue was,1
business including,1
a fiveyear term commencing,1
the increase was,2
expense was primarily,1
gross profit increased,1
distribution selling,1
millioncharge related,1
acquisitionwe recorded,1
plan see,1
income increased,1
margin decreased,1
rate was,1
rate was also,1
ratesnet income was,1
net loss was,1
management believes,1
the customer based,1
trendsin determining,1
the required allowance requires,2
trade receivables,2
collectability is,1
expense was,2
forany period presented,1
price recorded,2
fair value based,2
that determination is,2
the impairment charge was,3
the investment was,3
impairment test requires,2
thefair value exceeds,1
no further evaluation is,2
no impairment loss is,2
amount exceeds,1
the fair value is,2
companyresideswe utilize,1
test requires,2
growth operating,2
return required,2
capital includes,2
equity including,1
method is,4
value derived,1
expense deferred,1
tobe paid,1
purposeswe have,1
judgment is,1
the positionwe believe,1
paragraphs are,1
a loss has,2
the amount is reasonably,1
aloss is either,1
an additional loss has,2
loss has,2
provision is,2
the option expected,1
volatility is,1
the compensationexpense associated,1
the reserve estimates,1
appropriate based,2
the multicurrency revolving,1
facility thereceivables,1
dollar denominated,1
liquidity needs,1
time be,1
balance canrequire,1
shortterm capital needs,1
shortterm working capital needs,1
advance ofsecuring,1
loanswe have,1
rating ranging,2
time issue,2
time amounts,2
program does not,2
anaccordion feature whereby,1
turn sells,2
sourceswe have,1
note revolving,2
fund shortterm,1
principal payment is,4
the margin is,4
thecash consideration paid,1
consideration paid,1
a program allowing,1
availability remaining,3
program permitted,1
a sixmonth period beginning,3
ofissuer capped,1
common stockwe accounted,1
warrant hedging,1
the above premium was,3
the sixmonth period beginning,1
owner see,2
arrangement whichexpires,1
this liability represents,1
liability has,1
cash provided,3
the month ends,1
the prior fiscal year was,1
customer thatoccurred,1
period based,2
end working capitaladditionally,1
cash flows,1
resource planning,1
customer ordering,1
cash acquired,3
cash used,2
repurchaseprogramwe used,1
the potential dilution associated,1
increasesdividend increases,1
the year based,1
cash invested,1
foreign currency denominated forward,1
foreign currency denominated,2
thisreport are,1
intend plan continue,1
track believe,1
generic pharmaceutical pricing including,1
regulatory environment including,1
litigation including,1
the reserve recorded,1
process initiatives,1
control including,1
foreign expansion including,1
ability toreturn,1
the period ended,3
schedule listed,1
schedule are,1
responsibility is,2
andschedule based,1
auditswe conducted,1
an audit includesexamining,1
evidence supporting,1
all material respects,4
report dated,2
value authorized,1
translation adjustments,1
plan funded,1
share vesting,4
net cash provided,1
the adoption had,2
the quarter ended,2
value exceeds,2
revenue arising,1
principle is,2
the entity expects,1
effective date ofasu,1
retrospective application is,1
revenue is,1
this preliminary assessment is,1
a modified retrospective application is,1
a retrospective application is,1
the impact ofadopting,1
revenue andrepresented approximately,1
financial conditionand maintains,1
the company records,4
a loss is,1
policy prohibits,1
tradingpurposesthe company had,1
the weighted average exchange ratesfor,1
the company elected,2
the fair value exceeds,1
the discount rateis,1
actual future cashflows,1
the fair value derived,1
a result determined,1
longterm based,1
availableforsale was,1
all ofwhich was,1
the company performs,1
expense is,2
valuation whichapproximates,1
provision isaffected,1
equipment are,1
maintenance arecharged,1
software developed,1
preliminary stage activities0,1
an arrangement exists,1
renderedthe price is,1
collectability is reasonably,1
risk associated,1
profit earned,1
any year presentedsharebased,1
option grantsusing,1
restricted stock restricted,1
common stock sharebased,1
compensation paid,1
model approach,1
andthe related,1
an adjustment was,1
hadbeen used,1
expense starting,1
billionmwi is,1
price was,2
price exceeded,2
name was,1
the acquisition are not,2
the acquired softwaretechnology is,1
the company completed,2
benefit is,1
the company determined,1
a private letter rulingfrom,1
benefitadjustment had,1
information is,1
expiration dates,1
the company increased,2
allowance is,1
this amount was not,1
allowance ondeferred,1
loss carryforwardsin,1
the company had,1
position related,1
reserve recognized,1
a reduction ofunrecognized,1
the company was,3
feature whereby,1
the facility is,1
a financing vehicleutilized,1
rate relative,1
accountswhich are generally,1
an additional covenant requires,1
debt are,1
thereafterinterest paid,1
asotherwise provided,1
common stock are,3
cash settled,2
the financialinstitution delivered,1
common stock includes,1
common stock received,1
share exercisableduring,1
issuer capped,1
cash settledin,1
the sixmonthperiod beginning,1
share is,2
stock restricted,3
outstanding fiscal year ended,1
plan covering,2
an internal committee comprised,1
plan administratorsdefined,1
the company obtained,1
the company transferred,1
each additional0 invested,1
this unfunded plan provides,1
keymanagement including,1
compensation exceeded,1
limit established,2
compensation exceeds,1
the amount deferred,1
compensation allocated,1
stock creditsbased,1
each full share credited,1
common stock have,1
liability relating,1
the option is,1
the company estimates,1
model expected,1
expense relating,2
restricted sharesis expensed,1
the extent towhich,1
expense associated,1
period ended,1
thecompany withhold,1
each participant is,1
the company has,2
other fiscal year ended,1
dealrelated transaction costs,1
dispute settlements,1
the company incurred,1
the company began,1
company incurred,1
thecompany incurred,1
a liability has,1
litigation arising,1
a private person knownas,1
the complaint imposes,1
the casewas filed,1
false claim submitted,1
the complaint is,1
complaint filed,1
other industry participant,1
these mattersare resolved,1
the guilty plea resolves,1
the federal criminal investigation related,1
the year ended,3
a grand jury proceeding,1
additional information related,1
anadministrative subpoena requesting,1
the company is,1
matter involving,1
the settlement is,1
the company has not,1
uncertainty remains,1
this matter was,1
thecompany recognized,1
a county childrens,1
this motion wasmade,1
company is vigorously,1
the company regarding,1
andwill be,1
the litigation including,1
entity controlled,1
a minorityinvestor completes,1
class ie,1
the settlement fundsduring,1
chief operating,1
whosefunction is,1
providersother consists,1
reportable segment operating,1
credit expenseacquisitionrelated,1
segmentthe following,1
amortization includes,1
expensethe following,1
0total capital expenditures,1
market accounts,1
inputsthe recorded,1
longterm debt see,1
longterm debt was,1
accrual fiscal year ended,1
the company announced,1
thetransaction is,1
clinicsthe acquisition strengthens,1
independent community pharmaciesdividend,1
the quarterly dividend paid,1
that information required,2
management haveevaluated,1
theperiod covered,1
the fiscal quarter ended,6
financial reporting is,2
reasonable assurance regarding,5
accounting principles,1
financial reporting includes,2
the company are,1
management assessed,1
this assessment management used,1
management has,1
financial reporting was,2
the effectiveness ofamerisourcebergens,1
this report is,3
management is,1
financial reporting included,1
auditwe conducted,1
audit included,1
internal control based,1
audit provides,1
a process designed,1
thecompany are,1
information appearing,5
this reportwe adopted,1
schedule is,1
trustee related,9
form 0kfiled,2
thefiscal quarter ended,2
buyer dated,1
originator incorporated,2
administrator incorporated,5
asadministrator incorporated,2
recipient incorporated,1
guarantor incorporated,1
the quarter endedmarch,1
administrative agent incorporated,1
v theconsolidated,1
reproductioneach marked,1
exhibit is,1
duly authorized,1
this report has,1
atend ofperiod,1
year ended,2
no such impairment charge recorded,1
this report does not,2
the period covered,4
other financial information included,2
material information relating,2
prepared b designed,2
d disclosed,2
the date hereof,2
the information contained,2
statement required,1
this certification accompanies,1
the extent required,1
